Today: 9 June 2026
Rolls-Royce shares end the week higher as buyback rolls on — what to watch before results
7 February 2026
1 min read

Rolls-Royce shares end the week higher as buyback rolls on — what to watch before results

London, Feb 7, 2026, 08:41 (GMT) — The market is shut.

  • Rolls-Royce finished Friday up 1.78%, outperforming the FTSE 100.
  • Company revealed it’s set to buy back more shares, dipping again into its £200 million repurchase program.
  • Attention now turns to full-year results on Feb. 26, with the buyback set to wrap up by the end of the month.

Rolls-Royce Holdings finished Friday’s session 1.78% higher at 1,229.0 pence, wrapping up the week stronger as the London market heads into a break until Monday.

The shares topped the FTSE 100, which managed gains as well, ending just below their 52-week peak on lighter-than-usual volume.

Just ahead of the weekend, the engine-maker disclosed its latest round of repurchases, chipping away at its £200 million share buyback. The scheme cuts the share count by scooping up stock and cancelling those shares.

Rolls-Royce disclosed in a Feb. 6 statement that it picked up 742,570 ordinary shares the day prior, Feb. 5, snapping them up across various venues for an average of about 1,213 pence apiece—weighted by volume. These shares, according to the company, will be cancelled. Since launching the programme, Rolls-Royce has now bought back a total of 12,655,497 shares.

Why it matters: The buyback’s been propping up the market just as investors weigh whether Rolls-Royce’s recent run has legs through 2026—and look for management’s next word on cash and demand.

Rolls-Royce said in December that its buyback programme will continue until Feb. 24, and UBS is handling market purchases for the company.

Coming up fast, Rolls-Royce plans to release its 2025 full-year results on Feb. 26, per the company’s investor calendar.

This week’s trading has been a rough ride. Shares dropped 0.82% on Thursday, saw a rebound Friday, and now traders are eyeing Monday to see if buyers step back in as liquidity comes back.

Another angle: the stock remains well below its recent high of about 1,306.5 pence, based on Hargreaves Lansdown’s figures. Investors are on edge for any change in commentary on margins or delivery snags in the aerospace supply chain.

Risks go both directions here. Yes, a buyback props up earnings per share by lowering the share count. Still, it won’t protect the stock if guidance falls short, aftermarket appetite fades, or investors start to feel the price is outpacing what the fundamentals can justify right now.

Once trading picks up again, attention turns to the next buyback announcement, any new updates from the company, and then the main events: Feb. 24 marks the scheduled end of the buyback, followed by the full-year earnings on Feb. 26.

Stock Market Today

  • Higher Bond Yields Pressure Stock Investors Amid Key Treasury Auctions and Fed Meeting
    June 9, 2026, 9:37 AM EDT. Bond yields are rising as markets brace for critical U.S. economic data, Treasury auctions, and a Federal Reserve meeting. Increasing yields make borrowing costlier and can divert investment away from stocks, creating anxiety among stock investors. The bond market's adjustment signals investor caution about inflation and interest rate trajectories. This realignment ahead of pivotal events is causing discomfort for equities, highlighting the interconnectedness of fixed income and stock markets.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
AmpliTech’s 5G Radio Test Moves AMPG Shares

AmpliTech’s 5G Radio Test Moves AMPG Shares

9 June 2026
AMPG soared 26.7% to $6.57 after AmpliTech revealed its 64T64R Massive MIMO radio was the only one of its kind at O-RAN PlugFest, showing interoperability with major carriers’ equipment, but no new orders were announced, leaving sales conversion as the key investor focus.
Xero share price slides 14% in a week — what to watch next for ASX:XRO
Previous Story

Xero share price slides 14% in a week — what to watch next for ASX:XRO

No $2,000 IRS stimulus check is coming in February 2026 — but Trump’s tariff-check talk keeps the rumors alive
Next Story

No $2,000 IRS stimulus check is coming in February 2026 — but Trump’s tariff-check talk keeps the rumors alive

Go toTop